Global Obesity Treatment Market Faces Shake-Up
The expiration of a key patent on semaglutide—the active ingredient in blockbuster weight-loss drugs Ozempic and Wegovy has set the stage for a dramatic expansion of access to obesity treatments, with India’s generic pharmaceutical industry poised to flood the market with lower-cost alternatives that could fundamentally alter the economics of weight management worldwide….